| pubmed-article:6529146 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6529146 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:6529146 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:6529146 | lifeskim:mentions | umls-concept:C0428447 | lld:lifeskim |
| pubmed-article:6529146 | lifeskim:mentions | umls-concept:C1287367 | lld:lifeskim |
| pubmed-article:6529146 | lifeskim:mentions | umls-concept:C0280606 | lld:lifeskim |
| pubmed-article:6529146 | lifeskim:mentions | umls-concept:C0412467 | lld:lifeskim |
| pubmed-article:6529146 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6529146 | pubmed:dateCreated | 1985-3-26 | lld:pubmed |
| pubmed-article:6529146 | pubmed:abstractText | A series of 178 urinary stones is analysed qualitatively during a three year period from 1980 to 1982. The majority (96%) of stones orginate from the upper tract. Calcium oxalate stones are the commonest entity seen in the western countries but less than 20% of such stones occur locally. A large proportion consists of mixed stones and one third are infective as triple phosphate is present. 20% contain urate as a constituent whereas relatively pure urate stones constitute 4%. The true incidence of pure urate stones is higher (about 10%) as we have been dissolving them with alkalinisation of urine without surgery. Idiopathic hypercalciura occurs in 11.8% and none has persistent hypercalcaemia. Hyperuricosuria which is commoner, occurs in 24% of patients. It is important to identify this group as it results in the formation of metabolically active stones, and they can be treated with allopurinol to prevent recurrence of stones. | lld:pubmed |
| pubmed-article:6529146 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6529146 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6529146 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6529146 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:6529146 | pubmed:issn | 0304-4602 | lld:pubmed |
| pubmed-article:6529146 | pubmed:author | pubmed-author:TanE CEC | lld:pubmed |
| pubmed-article:6529146 | pubmed:author | pubmed-author:LokC KCK | lld:pubmed |
| pubmed-article:6529146 | pubmed:author | pubmed-author:IiYY | lld:pubmed |
| pubmed-article:6529146 | pubmed:author | pubmed-author:FoongW CWC | lld:pubmed |
| pubmed-article:6529146 | pubmed:author | pubmed-author:TungK HKH | lld:pubmed |
| pubmed-article:6529146 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6529146 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:6529146 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6529146 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6529146 | pubmed:pagination | 616-9 | lld:pubmed |
| pubmed-article:6529146 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:meshHeading | pubmed-meshheading:6529146-... | lld:pubmed |
| pubmed-article:6529146 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6529146 | pubmed:articleTitle | Stone composition and metabolic study in urinary calculous disease. | lld:pubmed |
| pubmed-article:6529146 | pubmed:publicationType | Journal Article | lld:pubmed |
